Cargando…
Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs
BACKGROUND: Optimal techniques for DC generation for immunotherapy in cancer are yet to be established. Study aims were to evaluate: (i) DC activation/maturation milieu (TNF-α +/- IFN-α) and its effects on CD8+ hTERT-specific T cell responses to class I epitopes (p540 or p865), (ii) CD8+ hTERT-speci...
Autores principales: | Aloysius, Mark M, Mc Kechnie, Alastair J, Robins, Richard A, Verma, Chandan, Eremin, Jennifer M, Farzaneh, Farzin, Habib, Nagy A, Bhalla, Joti, Hardwick, Nicola R, Satthaporn, Sukchai, Sreenivasan, Thiagarajan, El-Sheemy, Mohammed, Eremin, Oleg |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674878/ https://www.ncbi.nlm.nih.gov/pubmed/19298672 http://dx.doi.org/10.1186/1479-5876-7-18 |
Ejemplares similares
-
Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha
por: Satthaporn, Sukchai, et al.
Publicado: (2008) -
The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers
por: Kaewkangsadan, Viriya, et al.
Publicado: (2017) -
Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
por: Inderberg-Suso, Else-Marit, et al.
Publicado: (2012) -
Abnormal T regulatory cells (Tregs: FOXP3(+), CTLA-4(+)), myeloid-derived suppressor cells (MDSCs: monocytic, granulocytic) and polarised T helper cell profiles (Th1, Th2, Th17) in women with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC) and surgery: failure of abolition of abnormal treg profile with treatment and correlation of treg levels with pathological response to NAC
por: Verma, Chandan, et al.
Publicado: (2013) -
siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells
por: Li, Hua, et al.
Publicado: (2015)